Zobrazeno 1 - 10
of 55
pro vyhledávání: '"39"'
Autor:
R. Carvalho Santos, L. Araújo Aragão, F. Moreira Batista Aguiar, C.M. Sampaio Viana, R. Fernandes Viana De Araujo, I. Lopes De Medeiros, A.S. Monteiro Nogueira, A. Gomes Neto, L. Gomes Catunda, R. Fava Alencar
Publikováno v:
Transplantation proceedings. 50(3)
Introduction The lung transplantation (LTx) program began in Ceara in 2011 and the first LTx was performed on June 11, 2011. The aim of this study was to present the initial results of the 6-year experience of our program. Methods We retrospectively
Autor:
Ji Hoon Shin, Jai Won Chang, Shin Hwang, Dong-Hwan Jung, Tae-Yong Ha, Chul-Soo Ahn, Deok-Bog Moon, Gi-Won Song, Ki-Hun Kim, Kyoung Sik Cho, Soon Bae Kim, Sung-Gyu Lee
Publikováno v:
Transplantation Proceedings. 53:1719-1725
Background Most guidelines recommend simultaneous liver-kidney transplantation (SLKT) in patients with liver cirrhosis (LC) and severe chronic kidney disease (CKD) over liver transplantation alone (LTA). CKD, however, is not irreversible. This study
Autor:
A. Kheder, F. Ben Hamida, H. Hedri, Ezzedine Abderrahim, Karim Zouaghi, S. Ezzine, I. Ben Abdallah, H. Ben Maiz, Mondher Ounissi, I. Helal, K. Ayed, R. Bardi, T. Ben Abdallah, M. Chrif, S. Barbouche
Publikováno v:
Transplantation Proceedings. 39:2547-2549
Studies looking at the type of pretransplantation renal replacement therapy on graft and patient survivals after kidney transplantation have produced conflicting results. Therefore, we studied the effect of pretransplantation dialysis modality (perit
Publikováno v:
Transplantation proceedings. 36(4)
Abstract Simultaneous pancreas-kidney transplantation (SPK) recipients have longer survival compared to type 1 diabetes mellitus (DM1) cadaveric kidney recipients. However, DM1 living-related kidney transplant (KTX-LR) recipients have the same mortal
Publikováno v:
Transplantation proceedings. 53(9)
Background Autoimmune liver diseases (ALDs) (primary biliary cholangitis, primary sclerosing cholangitis [PSC], autoimmune hepatitis [AIH]) can present extrahepatic autoimmune manifestations, the most frequent being inflammatory bowel disease (IBD),
Autor:
Itsuhiro Takizawa, Masahiro Ikeda, Hidefumi Aoyama, Kazuhide Saito, Yoshihiko Tomita, Tsutomu Nishiyama, Noboru Hara, Yuki Nakagawa, Masayuki Tasaki, Hajime Umezu, Ryo Maruyama, Kazutoshi Yamana, Gen Kawaguchi, Takashi Kasahara, Motoki Kaidu, Fumio Ishizaki
Publikováno v:
Transplantation Proceedings. 51:774-778
Background Brachytherapy is one of the standard treatments for localized prostate cancer (CaP). However, the feasibility of brachytherapy for renal transplant recipients (RTRs) is still uncertain. Materials and methods Between August 2007 and March 2
Publikováno v:
Transplantation Proceedings. 50:3249-3254
Preceding solo kidney transplantation for type 1 diabetes with end-stage renal failure is controversial because of less pancreatic graft survival in pancreas transplantation after kidney transplantation (PAK) than in simultaneous pancreas and kidney
Autor:
Danny Ramzy, Fardad Esmailian, Jaime Moriguchi, Joshua Chan, Jon A. Kobashigawa, D. Megna, Joanna Chikwe, Dominic Emerson, Michelle M. Kittleson, Qiudong Chen, Alfredo Trento, Jignesh Patel, Ryan Levine, Sadia Dimbil
Publikováno v:
Transplantation proceedings. 53(1)
Background Indications for heart transplantation are expanding to include amyloid light chain (AL) and transthyretin-related (TTR) amyloidosis. Previously, AL amyloid had been a contraindication to heart transplantation given inferior outcomes. These
Autor:
Michał Grąt, Krzysztof Zając, Marcin Morawski, Waldemar Patkowski, Michał Wierzchowski, Krzysztof Zieniewicz, Maciej Jastrzębski, Maciej Krasnodębski, Piotr Remiszewski
Publikováno v:
Transplantation proceedings. 52(8)
Background Hepatic epithelioid hemangioendothelioma (HEHE) is a rare vascular tumor with indolent behavior in terms of malignancy. The treatment of choice is either resection in the case of resectable lesions or liver transplantation (LT) for the dis
Autor:
M. Soares, J. Gandara, H.P. Miranda, Vítor P. Lopes, R. Vizcaino, J. Daniel, S. Pereira, Sofia Ferreira, C.M. Cruz
Publikováno v:
Transplantation Proceedings. 48:2344-2347
Introduction In liver transplantation, late graft dysfunction can have several causes, particularly rejection, infection, vascular, biliary complications, and others, usually suspected by abnormal liver tests. However, normal liver tests do not confi